Freedom of Information request on in response to a recent FOI made ref. 21/1152 (FOI 21/1247)
Published 31 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-13-december-2021/freedom-of-information-request-on-in-response-to-a-recent-foi-made-ref-211152-foi-211247
FOI 21/1247
16th December 2021
Dear,
Thank you for your email, dated 23rd November 2021, in which you asked:
“In response to a recent FOI made ref. 21/1152 it was confirmed there have been 3 fatal reports made to MHRA for all yellow card reports made for Isle of Man for all Covid-19 vaccines up to the 3rd November 2021.
Of these 3 Fatal Reports please can you confirm the following:-
- The time after the vaccination that the death occurred.
- The age and sex of the deceased.
- Any known underlying health conditions of the deceased.”
The information requested is withheld under Section 35 of the FOI Act. Section 35 of the FOI Act protects the internal deliberative process as it relates to government policy making. The MHRA and Department of Health will be undertaking discussions around the level of data and associated fields that should be placed in the public domain. Until this policy decision has been agreed we are unable to release additional data beyond that in the format that is included in the weekly summary of Yellow Card reporting.
I hope the information provided is helpful; however, if you are dissatisfied with the handling of your
request, you have the right to ask for an internal review. Internal review requests should be submitted
within two months of the date of this response; and can be addressed to this email address.
Please remember to quote the reference number above in any future communications.
Yours sincerely,
FOI Team,
Vigilance and Risk Management of Medicines Division